{"id":"https://openalex.org/W7207629557","doi":"https://doi.org/10.18609/cgti.2026.094","title":"Benchmarking emerging chromatographic platforms for mRNA-LNP characterization and scalable process enablement","display_name":"Benchmarking emerging chromatographic platforms for mRNA-LNP characterization and scalable process enablement","publication_year":2026,"publication_date":"2026-09-03","ids":{"openalex":"https://openalex.org/W7207629557","doi":"https://doi.org/10.18609/cgti.2026.094"},"language":"en","primary_location":{"id":"doi:10.18609/cgti.2026.094","doi":"https://doi.org/10.18609/cgti.2026.094","is_oa":true,"landing_page_url":"https://doi.org/10.18609/cgti.2026.094","pdf_url":"https://www.insights.bio/api/article/3944/download","source":{"id":"https://openalex.org/S4210198480","display_name":"Cell and Gene Therapy Insights","issn_l":"2059-7800","issn":["2059-7800","2397-0545"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell and Gene Therapy Insights","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.insights.bio/api/article/3944/download","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093269297","display_name":"Sergeja Lebar","orcid":"https://orcid.org/0009-0001-6381-439X","observed_orcids":["https://orcid.org/0009-0001-6381-439X"]},"institutions":[{"id":"https://openalex.org/I2957750942","display_name":"BIA Separations (Slovenia)","ror":"https://ror.org/03f2kwz12","country_code":"SI","type":"company","lineage":["https://openalex.org/I2957750942"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Sergeja Lebar","raw_affiliation_strings":["Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia","institution_ids":["https://openalex.org/I2957750942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079199147","display_name":"Tristan Kova\u010di\u010d","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2957750942","display_name":"BIA Separations (Slovenia)","ror":"https://ror.org/03f2kwz12","country_code":"SI","type":"company","lineage":["https://openalex.org/I2957750942"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Tristan Kova\u010di\u010d","raw_affiliation_strings":["Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia","institution_ids":["https://openalex.org/I2957750942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093269296","display_name":"Ana Ferjan\u010di\u010d Budihna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2957750942","display_name":"BIA Separations (Slovenia)","ror":"https://ror.org/03f2kwz12","country_code":"SI","type":"company","lineage":["https://openalex.org/I2957750942"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Ana Ferjan\u010di\u010d Budihna","raw_affiliation_strings":["Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia","institution_ids":["https://openalex.org/I2957750942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016489740","display_name":"J\u00e9r\u00e9mie Parot","orcid":"https://orcid.org/0000-0003-2044-1631","observed_orcids":["https://orcid.org/0000-0003-2044-1631"]},"institutions":[{"id":"https://openalex.org/I4387930256","display_name":"SINTEF Industry","ror":"https://ror.org/0422tvz87","country_code":"NO","type":"facility","lineage":["https://openalex.org/I173888879","https://openalex.org/I4387930256"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Jeremie Parot","raw_affiliation_strings":["SINTEF Industry, Department of Biotechnology and Nanomedicine, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SINTEF Industry, Department of Biotechnology and Nanomedicine, Trondheim, Norway","institution_ids":["https://openalex.org/I4387930256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001345697","display_name":"Alicja Molska","orcid":"https://orcid.org/0000-0001-8854-6953","observed_orcids":["https://orcid.org/0000-0001-8854-6953"]},"institutions":[{"id":"https://openalex.org/I4387930256","display_name":"SINTEF Industry","ror":"https://ror.org/0422tvz87","country_code":"NO","type":"facility","lineage":["https://openalex.org/I173888879","https://openalex.org/I4387930256"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Alicja Molska","raw_affiliation_strings":["SINTEF Industry, Department of Biotechnology and Nanomedicine, Trondheim, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SINTEF Industry, Department of Biotechnology and Nanomedicine, Trondheim, Norway","institution_ids":["https://openalex.org/I4387930256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079430785","display_name":"Nejc Pavlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2957750942","display_name":"BIA Separations (Slovenia)","ror":"https://ror.org/03f2kwz12","country_code":"SI","type":"company","lineage":["https://openalex.org/I2957750942"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Nejc Pavlin","raw_affiliation_strings":["Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia","institution_ids":["https://openalex.org/I2957750942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007570896","display_name":"Mojca Bav\u010dar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2957750942","display_name":"BIA Separations (Slovenia)","ror":"https://ror.org/03f2kwz12","country_code":"SI","type":"company","lineage":["https://openalex.org/I2957750942"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Mojca Bav\u010dar","raw_affiliation_strings":["Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia","institution_ids":["https://openalex.org/I2957750942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5149513837","display_name":"Tja\u0161a Leban","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2957750942","display_name":"BIA Separations (Slovenia)","ror":"https://ror.org/03f2kwz12","country_code":"SI","type":"company","lineage":["https://openalex.org/I2957750942"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Tja\u0161a Leban","raw_affiliation_strings":["Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia","institution_ids":["https://openalex.org/I2957750942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007745092","display_name":"Mojca Tajnik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2957750942","display_name":"BIA Separations (Slovenia)","ror":"https://ror.org/03f2kwz12","country_code":"SI","type":"company","lineage":["https://openalex.org/I2957750942"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Mojca Tajnik","raw_affiliation_strings":["Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia","institution_ids":["https://openalex.org/I2957750942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037280417","display_name":"Mojca Tajnik Sbaizero","orcid":"https://orcid.org/0009-0004-5245-5266","observed_orcids":["https://orcid.org/0009-0004-5245-5266"]},"institutions":[{"id":"https://openalex.org/I2957750942","display_name":"BIA Separations (Slovenia)","ror":"https://ror.org/03f2kwz12","country_code":"SI","type":"company","lineage":["https://openalex.org/I2957750942"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Mojca Tajnik Sbaizero","raw_affiliation_strings":["Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia","institution_ids":["https://openalex.org/I2957750942"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5093269298","display_name":"Andreja Gramc Livk","orcid":"https://orcid.org/0009-0006-8909-8439","observed_orcids":["https://orcid.org/0009-0006-8909-8439"]},"institutions":[{"id":"https://openalex.org/I2957750942","display_name":"BIA Separations (Slovenia)","ror":"https://ror.org/03f2kwz12","country_code":"SI","type":"company","lineage":["https://openalex.org/I2957750942"]}],"countries":["SI"],"is_corresponding":false,"raw_author_name":"Andreja Gramc Livk","raw_affiliation_strings":["Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sartorius BIA Separations, Ajdov\u0161\u010dina, Slovenia","institution_ids":["https://openalex.org/I2957750942"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"7","first_page":"767\u2013785","last_page":"767\u2013785"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.8773999810218811,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.8773999810218811,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.05270000174641609,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.0215000007301569,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.9869999885559082},{"id":"https://openalex.org/keywords/multi-angle-light-scattering","display_name":"multi-angle light scattering","score":0.7360000014305115},{"id":"https://openalex.org/keywords/uv-vis-detection","display_name":"UV-Vis detection","score":0.6930000185966492},{"id":"https://openalex.org/keywords/particle-size-distribution","display_name":"particle size distribution","score":0.5170000195503235},{"id":"https://openalex.org/keywords/critical-quality-attributes","display_name":"critical quality attributes","score":0.765999972820282},{"id":"https://openalex.org/keywords/nucleic-acid-therapeutics","display_name":"nucleic acid therapeutics","score":0.7059999704360962},{"id":"https://openalex.org/keywords/ionizable-lipids","display_name":"ionizable lipids","score":0.7129999995231628},{"id":"https://openalex.org/keywords/process-development","display_name":"process development","score":0.33799999952316284},{"id":"https://openalex.org/keywords/mrna-vaccines","display_name":"mRNA vaccines","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.5455999970436096},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.5224999785423279},{"id":"https://openalex.org/C48044578","wikidata":"https://www.wikidata.org/wiki/Q727490","display_name":"Scalability","level":2,"score":0.517300009727478},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.45879998803138733},{"id":"https://openalex.org/C24107716","wikidata":"https://www.wikidata.org/wiki/Q123619","display_name":"Nucleic acid","level":2,"score":0.4569999873638153},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.45399999618530273},{"id":"https://openalex.org/C86251818","wikidata":"https://www.wikidata.org/wiki/Q816754","display_name":"Benchmarking","level":2,"score":0.4505999982357025},{"id":"https://openalex.org/C2780841128","wikidata":"https://www.wikidata.org/wiki/Q5073781","display_name":"Characterization (materials science)","level":2,"score":0.41620001196861267},{"id":"https://openalex.org/C2780598303","wikidata":"https://www.wikidata.org/wiki/Q65921492","display_name":"Flexibility (engineering)","level":2,"score":0.40220001339912415},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.34459999203681946},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.33970001339912415},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3215000033378601},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.3174000084400177},{"id":"https://openalex.org/C8673954","wikidata":"https://www.wikidata.org/wiki/Q138845","display_name":"Microfluidics","level":2,"score":0.2833000123500824},{"id":"https://openalex.org/C177212765","wikidata":"https://www.wikidata.org/wiki/Q627335","display_name":"Workflow","level":2,"score":0.2639999985694885},{"id":"https://openalex.org/C2988729646","wikidata":"https://www.wikidata.org/wiki/Q838129","display_name":"Process development","level":2,"score":0.259799987077713},{"id":"https://openalex.org/C115901376","wikidata":"https://www.wikidata.org/wiki/Q184199","display_name":"Automation","level":2,"score":0.2597000002861023}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.18609/cgti.2026.094","doi":"https://doi.org/10.18609/cgti.2026.094","is_oa":true,"landing_page_url":"https://doi.org/10.18609/cgti.2026.094","pdf_url":"https://www.insights.bio/api/article/3944/download","source":{"id":"https://openalex.org/S4210198480","display_name":"Cell and Gene Therapy Insights","issn_l":"2059-7800","issn":["2059-7800","2397-0545"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell and Gene Therapy Insights","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.18609/cgti.2026.094","doi":"https://doi.org/10.18609/cgti.2026.094","is_oa":true,"landing_page_url":"https://doi.org/10.18609/cgti.2026.094","pdf_url":"https://www.insights.bio/api/article/3944/download","source":{"id":"https://openalex.org/S4210198480","display_name":"Cell and Gene Therapy Insights","issn_l":"2059-7800","issn":["2059-7800","2397-0545"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell and Gene Therapy Insights","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.428600013256073,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1314822473","display_name":"A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing system","funder_award_id":"101098944","funder_id":"https://openalex.org/F4320338448","funder_display_name":"HORIZON EUROPE European Innovation Council"},{"id":"https://openalex.org/G340228487","display_name":"NANOSPRESSO-NL: Local preparation of high-quality, personalized nucleic acid nanomedicines","funder_award_id":"NWA.1389.20.096","funder_id":"https://openalex.org/F4320321800","funder_display_name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek"}],"funders":[{"id":"https://openalex.org/F4320321800","display_name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","ror":"https://ror.org/04jsz6e67"},{"id":"https://openalex.org/F4320338448","display_name":"HORIZON EUROPE European Innovation Council","ror":"https://ror.org/05cx8cy07"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7207629557.pdf","grobid_xml":"https://content.openalex.org/works/W7207629557.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4406987174","https://openalex.org/W7108483062","https://openalex.org/W4401334300","https://openalex.org/W4206715271","https://openalex.org/W4396951014","https://openalex.org/W4409324451","https://openalex.org/W7172325530","https://openalex.org/W4407628748","https://openalex.org/W7202368090","https://openalex.org/W4391144896"],"abstract_inverted_index":{"Lipid":[0],"nanoparticles":[1],"(LNPs)":[2],"are":[3],"now":[4],"the":[5,61,131],"leading":[6],"delivery":[7],"platform":[8,114],"for":[9],"nucleic":[10,106],"acid":[11],"therapeutics,":[12],"supporting":[13],"applications":[14],"from":[15],"prophylactic":[16],"mRNA":[17],"vaccines":[18],"to":[19,103],"in":[20,24],"vivo":[21,25],"gene":[22],"editing,":[23],"CAR-T,":[26],"protein":[27],"replacement,":[28],"and":[29,41,47,70,85,90,110,125,129],"personalized":[30],"cancer":[31],"immunotherapy.":[32],"As":[33],"formulations":[34],"incorporate":[35],"novel":[36],"ionizable":[37],"lipids,":[38],"targeting":[39],"ligands,":[40],"multi-component":[42],"payloads,":[43],"analytical":[44],"complexity":[45],"increases,":[46],"no":[48],"single":[49],"method":[50],"can":[51],"capture":[52],"all":[53],"critical":[54],"quality":[55],"attributes":[56],"(CQAs).":[57],"This":[58,113],"study":[59],"benchmarks":[60],"PATfix":[62],"LNP":[63,76,118],"Switcher":[64,77],"Platform":[65],"against":[66],"established":[67],"(RiboGreen,":[68],"DLS)":[69],"emerging":[71],"(FFF-UV-MALS-DLS-RI)":[72],"techniques.":[73],"The":[74],"2D":[75],"uses":[78],"independent":[79],"flow":[80],"paths,":[81],"dual":[82],"UV-Vis/MALS":[83],"detection,":[84],"automated":[86],"switching":[87],"between":[88],"non-disruptive":[89],"denaturing":[91],"modes,":[92],"enabling":[93],"preparation-free":[94],"analysis":[95],"of":[96,135],"intact":[97],"particles":[98],"followed":[99],"by":[100],"online":[101],"disruption":[102],"quantify":[104],"encapsulated":[105],"acid,":[107],"free":[108],"mRNA,":[109],"lipid\u2013mRNA":[111],"adducts.":[112],"supports":[115],"integrated,":[116],"multi-parameter":[117],"characterization":[119],"that":[120],"aligns":[121],"process":[122],"development,":[123],"manufacturing,":[124],"evolving":[126],"regulatory":[127],"expectations,":[128],"complements":[130],"scalable,":[132],"preparative":[133],"purification":[134],"mRNA-LNPs":[136],"on":[137],"CIMmultus":[138],"OH":[139],"monoliths.":[140]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2026-09-04T00:00:00"}